MEDWATCH - THE FDA MEDICAL PRODUCTS REPORTING PROGRAM

被引：0
|
作者：
RHEINSTEIN, PH
机构：
来源：
AMERICAN FAMILY PHYSICIAN | 1993年 / 48卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：636 / 638
页数：3
相关论文
共 50 条
  • [41] Medical devices: FDA ends secret reporting system that hid failures
    Dyer, Owen
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2019, 365
  • [42] FDA's regulatory program for lasers and electronic products.
    Kent, SLB
    Dennis, JE
    [J]. HEALTH PHYSICS, 2003, 84 (06): : S226 - S226
  • [43] Medical error reporting software program development and its impact on pediatric units' reporting medical errors
    Unal, Aysun
    Intepeler, Seyda Seren
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2020, 36 (02) : 10 - 15
  • [44] The FDA may not regulate tobacco products as "drugs" or as "medical devices"
    Merrill, RA
    [J]. DUKE LAW JOURNAL, 1998, 47 (06) : 1071 - 1094
  • [45] ISPOR, the FDA, and the Evolving Regulatory Science of Medical Device Products
    O'Neill, Tyler
    Miksad, Rebecca
    Miller, Danelle
    Maloney, Lesley
    John, Ani
    Hiller, Carolyn
    Hornberger, John
    [J]. VALUE IN HEALTH, 2019, 22 (07) : 754 - 761
  • [46] A scoping review of reporting gaps in FDA-approved AI medical devices
    Muralidharan, Vijaytha
    Adewale, Boluwatife Adeleye
    Huang, Caroline J.
    Nta, Mfon Thelma
    Ademiju, Peter Oluwaduyilemi
    Pathmarajah, Pirunthan
    Hang, Man Kien
    Adesanya, Oluwafolajimi
    Abdullateef, Ridwanullah Olamide
    Babatunde, Abdulhammed Opeyemi
    Ajibade, Abdulquddus
    Onyeka, Sonia
    Cai, Zhou Ran
    Daneshjou, Roxana
    Olatunji, Tobi
    [J]. npj Digital Medicine, 2024, 7 (01)
  • [47] Suboptimal reporting of adverse medical events to the FDA Adverse Events Reporting System by nurse practitioners and physician assistants
    Ehrenpreis, Eli D.
    Sifuentes, Humberto
    Ehrenpreis, Jamie E.
    Smith, Zachary L.
    Marshall, Mike L.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2012, 11 (02) : 177 - 183
  • [48] Infections and human tissue transplants: Review of FDA MedWatch reports 2001-2004
    Wang S.
    Zinderman C.
    Wise R.
    Braun M.
    [J]. Cell and Tissue Banking, 2007, 8 (3) : 211 - 219
  • [49] Alzheimer's Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database
    Lehrer, Steven
    Rheinstein, Peter H.
    [J]. JOURNAL OF ALZHEIMERS DISEASE REPORTS, 2018, 2 (01) : 111 - 115
  • [50] Fueling the development of products for rare diseases: the impact of the FDA's orphan products grants program
    Imoisili, Menfo A.
    Mueller, Christine
    Needleman, Katherine I. Miller
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (08): : 807 - 815
12345